Have Questions?
FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW
Latest Talcum Powder Lawsuit Updates
Our attorneys are reviewing claims from women diagnosed with ovarian cancer or mesothelioma after long-term use of Johnson's Baby Powder, Shower-to-Shower, or other talc-based personal care products.
Claims are consolidated in MDL 2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation, in the U.S. District Court for the District of New Jersey before Judge Michael A. Shipp. Parallel state-court cases continue across multiple jurisdictions.
To qualify, claimants generally need long-term use of J&J talc products (typically years to decades) plus a documented diagnosis of ovarian cancer, mesothelioma, or another asbestos-linked cancer.
Fill out the form to check your eligibility and find out if you qualify to file a claim.
The litigation alleges that Johnson & Johnson knew its talc-based products were contaminated with asbestos for decades and continued marketing them as safe for daily use, including for feminine hygiene. Internal J&J documents discovered in litigation document concerns about asbestos contamination dating to the 1960s and 1970s.
Diagnoses being investigated by talcum powder attorneys:
- Ovarian Cancer (epithelial, including serous, endometrioid, and clear cell subtypes)
- Fallopian Tube Cancer
- Primary Peritoneal Cancer
- Mesothelioma (pleural, peritoneal, pericardial)
- Other asbestos-related cancers in long-term users
Status Update: J&J has made multiple attempts to resolve the litigation through bankruptcy (LTL Management in 2021 and 2023, Red River Talc in 2024). Each bankruptcy strategy has been rejected by federal courts or by the required vote of plaintiffs. The litigation continues in MDL 2738 and in state courts. New filings continue to be accepted.
2024 J&J Discontinuation: J&J discontinued sales of talc-based Baby Powder in North America in 2020 and globally in 2023, switching to cornstarch-based formulations. The discontinuation does not bar liability for past use.
Table of Contents
[show]- The asbestos contamination problem in cosmetic talc
- Cancers linked to talcum powder use
- Johnson & Johnson products at issue
- The LTL Management and Red River Talc bankruptcy fights
- MDL 2738 status and parallel state-court cases
- Who qualifies to file a talcum powder lawsuit
- How to file and statute of limitations
The Talc and Asbestos Problem
(Johnson's Baby Powder and Shower-to-Shower Cancer Claims, May 2026)
Talc is a naturally occurring mineral mined from the earth. In geological terms, talc deposits sit close to asbestos deposits. The two minerals form under similar conditions, and historically, talc ore has often contained asbestos contamination at the source.
Cosmetic talc is supposed to be mined from deposits free of asbestos. The plaintiffs' theory in MDL 2738 is that J&J's talc sources were not in fact free of asbestos and that the company knew it.
For decades, Johnson's Baby Powder and Shower-to-Shower were marketed for daily use on babies and adults, including for feminine hygiene. Long-term genital application is the central exposure pathway in the ovarian cancer claims. Inhalation exposure during routine use is the central exposure pathway in the mesothelioma claims.
"J&J's internal documents from the 1970s flagged asbestos in talc ore. The company kept selling the product for the next four decades."
The Asbestos Contamination Problem in Cosmetic Talc
Asbestos is a known human carcinogen. There is no safe level of asbestos exposure. The International Agency for Research on Cancer (IARC) classifies all six asbestos-mineral forms (chrysotile, amosite, crocidolite, tremolite, anthophyllite, and actinolite) as Group 1 carcinogens for mesothelioma and several other cancers. Tremolite and anthophyllite are the asbestos forms most commonly identified as cosmetic-talc contaminants because they share geological formation conditions with talc deposits.
Cosmetic talc has been required to be "asbestos-free" for decades. The historical industry test method, X-ray diffraction (XRD) combined with polarized light microscopy (PLM), is now widely understood to miss low levels of asbestos contamination that more sensitive modern methods can detect. Transmission electron microscopy (TEM) with selected area electron diffraction and energy-dispersive X-ray spectroscopy detects fibrous tremolite, anthophyllite, and other asbestos minerals at concentrations PLM misses. Plaintiff experts argue J&J's historical reliance on the less sensitive method allowed contaminated talc to pass routine product testing for decades. The talc-mining sources historically used by J&J included deposits in Vermont and Italy where talc and tremolite asbestos coexist in the ore body.
FDA testing in 2019 detected asbestos in one Johnson's Baby Powder sample, triggering a 33,000-bottle recall. Plaintiffs cite the recall as evidence that the contamination concerns were real and that older lots may have carried similar contamination.
The mechanism for ovarian cancer in long-term genital users is migration: talc and any asbestos contamination applied to the perineal area can travel up the reproductive tract to the ovaries over years of exposure. The cumulative inflammation and direct asbestos deposit are the alleged drivers of malignancy.
For mesothelioma cases, the inhalation exposure during routine baby powder use (in a baby's nursery, on an adult's skin) delivers asbestos fibers to the lung pleura. Mesothelioma has a long latency (often 20 to 40 years), so adult mesothelioma cases today often trace to childhood or young-adult exposures.
- Internal J&J documents from the 1960s and 1970s discussing asbestos contamination in talc ore have been discovered and admitted as exhibits
- The 2019 FDA recall confirmed asbestos in at least one batch of Johnson's Baby Powder
- Multiple jury verdicts in state court, including a $4.69B verdict in Missouri (later reduced) and a $2.1B Pennsylvania verdict, have been substantially upheld on appeal
- J&J's repeated bankruptcy efforts have been rejected, keeping the cases moving in trial courts
Cancers Linked to Talcum Powder Use
The litigation covers two distinct cancer types with different exposure pathways and different scientific bases.
Ovarian Cancer (Long-Term Genital Use)
Hard Truth: The plaintiff pool in the ovarian cancer track is women who used J&J talc products on the perineal area for years (often decades) and were later diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Epidemiological studies, internal J&J documents, and pathology evidence (talc particles identified in ovarian tissue at autopsy or surgery) support causation. Long-term frequent use is the strongest case profile.
Mesothelioma (Inhalation Exposure)
Hard Truth: Mesothelioma is asbestos-specific. There is no other established cause. Plaintiffs in the mesothelioma track include women who used J&J talc products on themselves, parents who applied baby powder to their children, and adults who were exposed as children. Pleural mesothelioma (in the lung lining) is most common; peritoneal mesothelioma (in the abdominal lining) also appears in talc cases. The 20-to-40-year latency means many current claimants trace exposure to childhood.
Wrongful Death Claims
Hard Truth: Both ovarian cancer and mesothelioma carry high mortality rates. Wrongful death and survival action claims are a significant portion of the docket. Surviving family members may pursue both wrongful death damages (for the family's losses) and a survival action (for the decedent's pre-death pain and suffering). The wrongful death clock typically runs from the date of death rather than the original diagnosis.
Johnson & Johnson Products at Issue
The MDL targets a defined set of products and the corporate entities responsible:
Named Products and Defendants
The flagship product. Sold continuously from the late 1890s through 2020 in North America (discontinued globally in 2023, replaced by cornstarch-based Johnson's Baby Powder). The talc formulation is the version at issue. Long-term users of the talc version are the core plaintiff population.
Marketed specifically for adult feminine hygiene from the 1960s through 2012 (when J&J sold the brand to Valeant, now Bausch Health). The "A sprinkle a day" advertising encouraged daily perineal use. Shower-to-Shower is heavily represented in the ovarian cancer plaintiff pool.
Johnson & Johnson (the parent) and Johnson & Johnson Consumer Inc. (now Kenvue, after the 2023 consumer-products spinoff) are both named. The bankruptcy entities (LTL Management, Red River Talc) were attempts to create separate liability vehicles. Each bankruptcy attempt failed; J&J's full corporate balance sheet remains exposed.
Imerys Talc America (formerly Luzenac America) was J&J's primary talc supplier for decades. Imerys filed for Chapter 11 bankruptcy in 2019 and resolved its talc liabilities through a trust. New Imerys talc claims are channeled to that trust. The MDL focus is on J&J as the manufacturer and marketer of the consumer products.
The Bankruptcy Strategy and Why It Keeps Failing
J&J has made three serious attempts to channel its talc liability into a bankruptcy proceeding rather than face individual trials.
The first was the 2021 LTL Management Chapter 11 filing (the "Texas Two-Step" maneuver). LTL was a subsidiary created to hold the talc liabilities. The Third Circuit rejected the bankruptcy in January 2023, finding LTL was not in financial distress and therefore not a legitimate Chapter 11 debtor.
The second was a refiled LTL bankruptcy in mid-2023, again rejected by the bankruptcy court in July 2023.
The third was the 2024 Red River Talc filing, which proposed a $9 billion to $10 billion settlement plan. Plaintiff voting and judicial review again rejected the structure.
HARD TRUTH: Each failed bankruptcy returns the cases to the trial courts. Each new bankruptcy attempt pauses individual proceedings temporarily. The pattern produces fits and starts in the litigation timeline. Speak with a talcum powder attorney to understand where the current pause or trial schedule stands.
MDL 2738 at a Glance
Key procedural facts every claimant should understand:
- Case caption: In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation, MDL No. 2738
- Court: U.S. District Court for the District of New Jersey, Trenton
- Judge: Hon. Michael A. Shipp
- Centralized: October 4, 2016, by the JPML
- Pending cases: Tens of thousands across the federal MDL and state-court dockets
- Parallel state-court litigation: Active in Missouri, California, Pennsylvania, New Jersey state courts, and others
- Bankruptcy history: Three failed J&J attempts (LTL 2021, LTL 2023, Red River Talc 2024)
Notable state-court bellwether and individual verdicts over the past decade have included substantial awards. The Missouri "St. Louis 22" verdict (Ingham et al. v. Johnson & Johnson) initially returned $4.69 billion for 22 plaintiffs, reduced post-trial and on appeal but largely upheld in significant respects. The Pennsylvania $2.1 billion Ellen Kleiner mesothelioma verdict and other multi-million-dollar awards have shaped settlement expectations.
Who Qualifies to File a Talcum Powder Lawsuit
Eligibility turns on use history and diagnosis.
- Use history: Multi-year (typically 5 years or more) use of Johnson's Baby Powder, Shower-to-Shower, or other J&J talc-based products. For ovarian cancer claims, perineal (genital) application is the relevant exposure pathway. For mesothelioma claims, any inhalation exposure during use of talc products qualifies for evaluation.
- Qualifying diagnosis: Ovarian cancer (any epithelial subtype), fallopian tube cancer, primary peritoneal cancer, or mesothelioma (pleural, peritoneal, or pericardial). Each diagnosis requires pathology confirmation.
- Medical records: Pathology reports, surgical operative reports, oncology treatment records, and imaging supporting the diagnosis.
- Use documentation: Receipts, family memory, photographs, and witness statements documenting the years of J&J product use. Detailed use documentation is rarely available; the intake team helps reconstruct what is needed.
- Diagnosis date: Diagnosis within the applicable statute-of-limitations window for your state. The discovery rule typically preserves claims for patients who only recently connected the cancer to talc use, often through news coverage of the litigation.
- Wrongful death: Surviving family of women who died of ovarian cancer or mesothelioma with documented J&J talc use may file. Wrongful death clock typically runs from the date of death.
The use-history documentation challenge is real but solvable. Family members, friends, and longstanding habits anchor the use timeline. The intake review walks through what is available.
Compensation Available in Talcum Powder Claims
Damages cover both economic and non-economic losses. Punitive damages have been a significant component in the state-court verdicts because of the internal corporate documents on what J&J knew.
Economic damages: medical bills for cancer treatment (surgery, chemotherapy, radiation, immunotherapy, ongoing oncology care), lost wages, lost earning capacity, future medical care, hospice costs in terminal cases.
Non-economic damages: pain and suffering from the cancer and treatment, emotional distress, loss of fertility (in younger women), loss of consortium, diminished quality of life.
Punitive damages: available where the evidence supports a finding that J&J knew about asbestos contamination in its talc and continued to market it as safe. Multiple state-court juries have awarded substantial punitive damages on this theory.
Wrongful death damages: in fatal cases, funeral and burial costs, loss of financial support, loss of consortium and companionship, and the decedent's pre-death pain and suffering through a survival action.
What Talcum Powder Settlement Values May Look Like
The repeated failed J&J bankruptcy attempts have prevented a global settlement matrix. Cases continue to be valued individually based on cancer stage, treatment course, age at diagnosis, survival or fatal outcome, and the strength of the use-history documentation.
Mesothelioma cases (because mesothelioma has a single accepted cause: asbestos) historically value higher than ovarian cancer cases. Long-term-use ovarian cancer cases value higher than shorter-use cases. Wrongful death cases with surviving spouses and minor children value higher than cases with no economic dependents.
State-court verdicts have ranged from low six figures to billions of dollars in multi-plaintiff trials. Settlement values within a future global matrix would tier by diagnosis, exposure, and treatment burden.
For broader context on injury valuation, see our explanation of what your injury case is worth and how the multiplier method and per diem method apply to serious-injury claims.
Filing Deadlines and Procedural Issues
The SOL clock typically starts when the plaintiff knew or should have known the cancer was linked to talc use. Public attention to the litigation (the 2018 Ingham verdict, the 2020 baby powder discontinuation, the bankruptcy news coverage) gives many plaintiffs a defensible discovery date well after their original diagnosis. Patients diagnosed years ago may still be within their filing window.
Product-liability statutes range from 1 year (Louisiana, Tennessee) to 6 years. Wrongful death statutes typically run from date of death and range similarly. Asbestos-specific exposure statutes apply in some states. Confirm your state's filing window through a free case review.
Each J&J bankruptcy attempt has paused individual proceedings temporarily. Each rejection has restarted them. The pattern has produced uneven case timelines. A talcum powder attorney monitors the current procedural posture and advises on filing timing.
Most federal-court talc cases are coordinated through MDL 2738 in D.N.J. Significant state-court litigation continues in Missouri (where many of the highest verdicts have come from), California, Pennsylvania, and New Jersey. Venue selection is strategic and depends on the plaintiff's residence, exposure history, and the strength of jurisdictional ties.
Defenses and Hurdles in Talcum Powder Cases
J&J's defense playbook in talc cases is well-developed after years of litigation.
First, causation. The defense argues that talc itself does not cause cancer and that any asbestos contamination, if present, was at levels too low to be carcinogenic. Plaintiffs counter with the IARC Group 1 carcinogen classification for asbestos, the FDA's 2019 detection of asbestos in J&J Baby Powder, and pathology evidence of talc particles in plaintiff tissue samples.
Second, alternative cause. Ovarian cancer has multiple risk factors including BRCA1 and BRCA2 mutations, Lynch syndrome, family history, age, parity, and hormonal factors. Mesothelioma has the BAP1 germline mutation as a documented genetic risk factor; some mesothelioma plaintiffs are also screened for BAP1 status as part of case workup. The defense will argue these alternative causes explain individual diagnoses rather than talc exposure. The strongest plaintiff cases lack significant alternative-cause risk factors and have clear documentation of long-term J&J product use.
Third, bankruptcy maneuvering. J&J's repeated attempts to channel liability into separate bankruptcy entities have not succeeded, but they have slowed the litigation. The next defense move is uncertain. The pattern reflects similar tactics across other long-running mass torts our firm handles, including the hair relaxer cancer litigation and the Roundup non-Hodgkin lymphoma cases.
None of these defenses defeat the litigation. They affect timeline and per-case value.
How to File a Talcum Powder Lawsuit
The intake process is straightforward when you work with a firm familiar with talc litigation.
Step one: free case review. Share your J&J product use history (which products, how long, how often), your cancer diagnosis, and your treatment course.
Step two: medical record collection. We pull pathology reports, oncology notes, surgical reports, and treatment records that document the diagnosis. For mesothelioma cases, asbestos-fiber analysis of tissue samples may be available and is reviewed.
Step three: filing strategy. Cases may be filed in MDL 2738 (D.N.J.) or in state court depending on residence, exposure history, and procedural strategy. A talcum powder lawyer evaluates which venue best fits the case.
Step four: plaintiff fact sheet. The MDL and most state-court coordinated proceedings require a detailed fact sheet documenting use history, medical history, and damages.
Step five: discovery and resolution. Through bellwether outcomes, individual settlement, or trial. Wrongful death cases proceed alongside personal-injury cases on parallel tracks.
Contingency fee. No money out of pocket. No fee unless we recover for you.
Time Pressure: Why Sooner Is Better Than Later
Talc cases are time-bound under state statutes of limitations. The discovery rule helps but does not eliminate deadlines. Statutes of repose in some states cap claims regardless of when the cancer was discovered. Wrongful death clocks run from date of death.
Use-history evidence is also easier to reconstruct closer in time. Family members who can confirm the years of baby powder use may not be available indefinitely.
If you used Johnson's Baby Powder or Shower-to-Shower long-term and were diagnosed with ovarian cancer or mesothelioma, the case review costs nothing and clarifies your filing window. Waiting can close doors that did not need to close.
Talcum Powder Lawsuit: Frequently Asked Questions
- Q: Does talcum powder cause cancer?
-
A: The litigation rests on asbestos contamination of cosmetic talc. Asbestos is an IARC Group 1 human carcinogen with no safe exposure level. FDA testing in 2019 detected asbestos in a sample of Johnson's Baby Powder, triggering a recall. Long-term perineal use is linked to ovarian, fallopian tube, and primary peritoneal cancers in epidemiological studies. Inhalation exposure is linked to mesothelioma. J&J contests causation; multiple juries have found the evidence sufficient.
- Q: I used Johnson's Baby Powder for decades and was diagnosed with ovarian cancer. Do I have a case?
-
A: Long-term Johnson's Baby Powder or Shower-to-Shower use with perineal application plus an ovarian cancer (or fallopian tube or primary peritoneal cancer) diagnosis is the core fact pattern for MDL 2738 ovarian cancer claims. The strongest cases have decades of use and limited alternative risk factors. A talcum powder attorney evaluates the specifics.
- Q: What is the average talcum powder settlement amount?
-
A: No global settlement matrix has been finalized because the J&J bankruptcy attempts have repeatedly failed. State-court verdicts have ranged from low six figures to multi-billion-dollar multi-plaintiff awards. Cases continue to be valued individually. Mesothelioma cases historically value higher than ovarian cancer cases because asbestos is the only accepted cause of mesothelioma. A free case review provides realistic case-specific guidance.
- Q: My mother died of ovarian cancer after using baby powder for decades. Can I file?
-
A: Yes. Wrongful death and survival action claims are a significant portion of MDL 2738 and the state-court dockets. The wrongful death clock typically runs from the date of death rather than the original diagnosis. Surviving spouses, children, and (in some states) parents have standing. See our overview of wrongful death claims.
- Q: J&J keeps trying to settle through bankruptcy. Does that affect my case?
-
A: Three bankruptcy attempts (LTL 2021, LTL 2023, Red River Talc 2024) have failed. Each attempt paused individual cases temporarily. Each rejection restarted them. The pattern creates timing uncertainty but does not prevent new claims from being filed. Whether J&J will try a fourth bankruptcy is unknown. A talcum powder lawyer monitors the procedural posture and advises on timing.
- Q: How long do I have to file a talc cancer lawsuit?
-
A: State law governs. Product-liability statutes of limitations range from 1 year to 6 years. Most states apply the discovery rule. The 2018 Ingham verdict, the 2019 FDA recall, the 2020 J&J discontinuation, and the bankruptcy news coverage are common discovery-date reference points. A free case review confirms your state's filing window.
- Q: How do I find a talcum powder lawyer near me?
-
A: Most federal cases are coordinated in MDL 2738 in the District of New Jersey. State-court cases concentrate in Missouri, California, Pennsylvania, and New Jersey. You do not need an attorney in your home state. You want a talc law firm with mass-tort experience and a documented track record in talc litigation. The case review is free and the contingency fee is standard.
- Q: What does a talcum powder attorney cost?
-
A: Contingency fee. No money out of pocket. No fee unless we recover for you. Standard structure for product-liability and mass-tort practice.
- Q: Is the talcum powder lawsuit a class action?
-
A: No. Talc cases are individual lawsuits coordinated through MDL 2738 in federal court and through parallel state-court dockets. Each plaintiff keeps her own case, her own injury profile, and her own settlement value. Mass tort is the formal term. Searchers commonly call it a class action because the structure looks similar from the outside, but each individual claim is its own lawsuit.
- Q: What is the difference between a Johnson's Baby Powder lawsuit and a Shower-to-Shower lawsuit?
-
A: Both are Johnson & Johnson talc products at issue in MDL 2738. Johnson's Baby Powder is the flagship product, sold for over a century until the 2020 North American discontinuation and 2023 global discontinuation. Shower-to-Shower was specifically marketed for adult feminine hygiene from the 1960s through 2012 (when J&J sold the brand to Valeant). Both are eligible products in the litigation. Long-term users of one or both can file under the same MDL.
- Q: I tested positive for BAP1 or BRCA. Does that hurt my talc case?
-
A: It complicates the alternative-cause analysis but does not automatically defeat the case. BAP1 germline mutations are associated with elevated mesothelioma risk; BRCA1 and BRCA2 mutations are associated with elevated ovarian cancer risk. The defense will argue these genetic factors explain the diagnosis. Plaintiffs counter with the documented J&J product-use history, the asbestos-mineral pathology evidence (where available), and the principle that a plaintiff is taken as found (the eggshell-plaintiff doctrine). Genetic risk factors are a case-evaluation issue, not an automatic bar. Speak with a talcum powder lawyer about how your specific facts apply.
- Q: I filed an Imerys talc trust claim. Can I still sue J&J?
-
A: Yes. The Imerys talc trust (created through the 2019 Imerys Talc America bankruptcy) resolved claims against the talc supplier, but it did not release J&J as the manufacturer of the consumer products. Plaintiffs who have filed Imerys trust claims continue to file separate J&J cases in MDL 2738 and state courts. The trust recovery is a separate compensation source. A talc attorney evaluates how the trust filing affects the J&J case strategy.
Talk to a Talcum Powder Lawyer Today
If you or a loved one used Johnson's Baby Powder, Shower-to-Shower, or other J&J talc products long-term and were diagnosed with ovarian cancer, fallopian tube cancer, primary peritoneal cancer, or mesothelioma, you may qualify to file a claim in MDL 2738 or in state court.
The case review is free and confidential. We handle talcum powder cases on contingency. You owe nothing unless we recover compensation for you.
Wrongful death and survival action claims are accepted on behalf of surviving family.
Free Case Evaluation
FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW
External Resources
Legal Representation
"Speak with our talcum powder attorneys for a free, confidential review of your potential claim. Past results vary based on the unique facts of each case."
Find out more >>